Related Experiment Video
Updated: Sep 19, 2026

Visualizing the DNA Damage Response in Purkinje Cells Using Cerebellar Organotypic Cultures
Published on: December 27, 2024
Friedreich Ataxia: From Genetics to Mechanism to Clinical Features
David R Lynch1, Sanjay I Bidichandani2, Jill S Napierala3
11Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA;
Abstract:
Friedreich ataxia is a slowly progressive neurodegenerative disorder caused by GAA expansions in the FXN gene that lead to decreased transcription of the mRNA coding for frataxin protein. Such deficiency leads to impaired iron sulfur cluster synthesis and various components of mitochondrial dysfunction. These events have been modeled in cellular and animal models, leading to assessment of many potential therapeutic agents based on enhancement of mitochondrial function or mitigation of frataxin deficiency. One agent, though not curative, has been approved for adults with Friedreich ataxia, but many approaches remain in therapeutic development.
More Related Videos
08:59Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
Related Concept Videos
Parkinson Disease ll: Pathophysiology
ATP Synthase: Mechanism
Huntington Disease l: Introduction
Translation
Translation
Pedigree Analysis